PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,847,887 | +24.5% | 10,456,258 | +0.9% | 0.00% | – |
| Q2 2023 | $11,921,641 | +17.4% | 10,366,644 | +8.2% | 0.00% | – |
| Q1 2023 | $10,156,795 | -18.2% | 9,581,884 | +17.2% | 0.00% | – |
| Q4 2022 | $12,422,235 | -25.2% | 8,172,524 | +4.3% | 0.00% | -100.0% |
| Q3 2022 | $16,612,000 | +60.2% | 7,835,549 | +1.3% | 0.00% | – |
| Q2 2022 | $10,370,000 | -32.0% | 7,738,235 | +7.1% | 0.00% | – |
| Q1 2022 | $15,246,000 | -42.8% | 7,225,641 | +0.6% | 0.00% | -100.0% |
| Q4 2021 | $26,635,000 | -25.6% | 7,179,445 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $35,789,000 | -23.7% | 7,172,311 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $46,919,000 | -7.7% | 7,195,940 | -2.4% | 0.00% | 0.0% |
| Q1 2021 | $50,816,000 | -25.1% | 7,375,625 | +10.9% | 0.00% | -50.0% |
| Q4 2020 | $67,822,000 | +177.6% | 6,649,272 | -4.7% | 0.00% | +100.0% |
| Q3 2020 | $24,428,000 | -32.1% | 6,979,105 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $35,988,000 | +55.5% | 7,211,987 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $23,142,000 | – | 6,806,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |